UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterization of a novel ATP‐sensitive K+ channel opener, A‐251179, on urinary bladder relaxation and cystometric parameters

British journal of pharmacology, 2007-06, Vol.151 (4), p.467-475

2007

Volltextzugriff (PDF)

A redesigned Escherichia coli triosephosphate isomerase restores growth properties in a bacterial strain useful for Immobilized Metal Affinity Chromatography (IMAC)

Journal of biotechnology, 2014-10, Vol.188, p.48-52

2014

Volltextzugriff (PDF)

In vivo evaluation of the potency and bladder‐vascular selectivity of the ATP‐sensitive potassium channel openers (–)‐cromakalim, ZD6169 and WAY‐133537 in rats

BJU international, 2003-02, Vol.91 (3), p.284-290

2003

Volltextzugriff (PDF)

A-61603, a potent alpha 1-adrenergic receptor agonist, selective for the alpha 1A receptor subtype

The Journal of pharmacology and experimental therapeutics, 1995-07, Vol.274 (1), p.97

1995

Volltextzugriff (PDF)

Preclinical pharmacological actions of (+/-)-(1'R,3R)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine

The Journal of pharmacology and experimental therapeutics, 1995-03, Vol.272 (3), p.1160

1995

Volltextzugriff (PDF)

Antiobesity evaluation of histamine H3 receptor (H3R) antagonist analogs of A-331440 with improved safety and efficacy

Inflammation research, 2005-04, Vol.54 Suppl 1 (S1), p.S27-S29

2005

Volltextzugriff (PDF)

Characterization of antihypertensive activity of ABBOTT-81988, a nonpeptide angiotensin II antagonist in the renal hypertensive rat

The Journal of pharmacology and experimental therapeutics, 1994-01, Vol.268 (1), p.427

1994

Volltextzugriff (PDF)

Structure-activity studies for a novel series of tricyclic substituted hexahydrobenz[e]isoindole alpha(1A) adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia (BPH)

Journal of medicinal chemistry, 2000-04, Vol.43 (8), p.1586-1603

2000

Volltextzugriff (PDF)

2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonists

Journal of medicinal chemistry, 1993-09, Vol.36 (18), p.2676-2688

1993

Volltextzugriff (PDF)

Distinctions and contradistinctions between antiobesity histamine H3 receptor (H3R) antagonists compared to cognition-enhancing H3 receptor antagonists

Inflammation research, 2006-04, Vol.55 (S1), p.S42-S44

2006

Volltextzugriff (PDF)

Comparison of alpha 1-adrenoceptor agonists in canine urethral pressure profilometry and abdominal leak point pressure models

The Journal of urology, 2001-10, Vol.166 (4), p.1555-1559

2001

Volltextzugriff (PDF)

Antihypertensive activity of ABBOTT-81282, a nonpeptide angiotensin II antagonist, in the renal hypertensive rat

Pharmacology, 1993-09, Vol.47 (3), p.176-187

1993

Volltextzugriff (PDF)

Cardiovascular Effects of Orally Administered ABBOTT-81988, an Angiotensin II Antagonist, in Conscious Spontaneously Hypertensive Rats

American journal of hypertension, 1994-11, Vol.7 (11), p.975-983

1994

Volltextzugriff (PDF)

Assessment of pharmacology and potential anti-obesity properties of H 3 receptor antagonists/inverse agonists

Expert opinion on investigational drugs, 2005-03, Vol.14 (3), p.223-241

2005

Volltextzugriff (PDF)

Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity

The Journal of pharmacology and experimental therapeutics, 1998-05, Vol.285 (2), p.628

1998

Volltextzugriff (PDF)

Relationships between pharmacokinetics and blockade of agonist-induced prostatic intraurethral pressure and mean arterial pressure in the conscious dog after single and repeated daily oral administration of terazosin

The Journal of pharmacology and experimental therapeutics, 1997-08, Vol.282 (2), p.891

1997

Volltextzugriff (PDF)

2,4-Diaminopyrimidine Derivatives as Potent Growth Hormone Secretagogue Receptor Antagonists

Journal of medicinal chemistry, 2006-04, Vol.49 (8), p.2568-2578

2006

Volltextzugriff (PDF)

Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity

Bioorganic & medicinal chemistry letters, 2005-06, Vol.15 (11), p.2752-2757

2005

Volltextzugriff (PDF)

Effects of selective and nonselective alpha-1-adrenoceptor antagonists on intraurethral and arterial pressures in intact conscious dogs

Pharmacology, 1996-12, Vol.53 (6), p.356-368

1996

Volltextzugriff (PDF)

Differential effects of Vitamin D analogs on bone formation and resorption

The Journal of steroid biochemistry and molecular biology, 2006, Vol.98 (1), p.72-77

2006

Volltextzugriff (PDF)

Structure−Activity Studies for a Novel Series of Bicyclic Substituted Hexahydrobenz[e]isoindole α1A Adrenoceptor Antagonists as Potential Agents for the Symptomatic Treatment of Benign Prostatic Hyperplasia

Journal of medicinal chemistry, 2001-06, Vol.44 (12), p.1971-1985

2001

Volltextzugriff (PDF)

Pharmacologic characterization of CHIR 2279, an N-substituted glycine peptoid with high-affinity binding for alpha 1-adrenoceptors

The Journal of pharmacology and experimental therapeutics, 1996-05, Vol.277 (2), p.885

1996

Volltextzugriff (PDF)

Pharmacological antagonism of α-adrenergic agonist induced increases in canine intraurethral pressure in vivo

Drug development research, 1995-03, Vol.34 (3), p.267-275

1995

Volltextzugriff (PDF)

Synthesis and Structure−Activity Relationships of a Novel Series of 2,3,5,6,7,9-Hexahydrothieno[3,2- b ]quinolin-8(4 H )-one 1,1-Dioxide K ATP Channel Openers: Discovery of (−)-(9 S )-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2- b ]quinolin-8(4 H )-one 1,1-Dioxide (A-278637), a Potent K ATP Opener That Selectively Inhibits Spontaneous Bladder Contractions

Journal of medicinal chemistry, 2004-06, Vol.47 (12), p.3163-3179

2004

Volltextzugriff (PDF)

Calcium-induced vasocontractions after alpha-2 adrenergic receptor activation in the dog saphenous vein: Comparison to calcium-induced contractions after potassium-depolarization

General pharmacology, 1990, Vol.21 (5), p.647-654

1990

Volltextzugriff (PDF)

1 – 25 von 798

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(618)
Mit Volltextzugriff
(698)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Characterization of a novel ATP‐sensitive K+ channel opener, A‐251179, on urinary bladder relaxation and cystometric parameters

A redesigned Escherichia coli triosephosphate isomerase restores growth properties in a bacterial strain useful for Immobilized Metal Affinity Chromatography (IMAC)

In vivo evaluation of the potency and bladder‐vascular selectivity of the ATP‐sensitive potassium channel openers (–)‐cromakalim, ZD6169 and WAY‐133537 in rats

A-61603, a potent alpha 1-adrenergic receptor agonist, selective for the alpha 1A receptor subtype

Antiobesity evaluation of histamine H3 receptor (H3R) antagonist analogs of A-331440 with improved safety and efficacy

Characterization of antihypertensive activity of ABBOTT-81988, a nonpeptide angiotensin II antagonist in the renal hypertensive rat

Structure-activity studies for a novel series of tricyclic substituted hexahydrobenz[e]isoindole alpha(1A) adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia (BPH)

2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonists

Distinctions and contradistinctions between antiobesity histamine H3 receptor (H3R) antagonists compared to cognition-enhancing H3 receptor antagonists

Comparison of alpha 1-adrenoceptor agonists in canine urethral pressure profilometry and abdominal leak point pressure models

Antihypertensive activity of ABBOTT-81282, a nonpeptide angiotensin II antagonist, in the renal hypertensive rat

Cardiovascular Effects of Orally Administered ABBOTT-81988, an Angiotensin II Antagonist, in Conscious Spontaneously Hypertensive Rats

Assessment of pharmacology and potential anti-obesity properties of H 3 receptor antagonists/inverse agonists

Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity

Relationships between pharmacokinetics and blockade of agonist-induced prostatic intraurethral pressure and mean arterial pressure in the conscious dog after single and repeated daily oral administration of terazosin

2,4-Diaminopyrimidine Derivatives as Potent Growth Hormone Secretagogue Receptor Antagonists

Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity

Effects of selective and nonselective alpha-1-adrenoceptor antagonists on intraurethral and arterial pressures in intact conscious dogs

Differential effects of Vitamin D analogs on bone formation and resorption

Structure−Activity Studies for a Novel Series of Bicyclic Substituted Hexahydrobenz[e]isoindole α1A Adrenoceptor Antagonists as Potential Agents for the Symptomatic Treatment of Benign Prostatic Hyperplasia

Pharmacologic characterization of CHIR 2279, an N-substituted glycine peptoid with high-affinity binding for alpha 1-adrenoceptors

Pharmacological antagonism of α-adrenergic agonist induced increases in canine intraurethral pressure in vivo

Calcium-induced vasocontractions after alpha-2 adrenergic receptor activation in the dog saphenous vein: Comparison to calcium-induced contractions after potassium-depolarization

Suchergebnisse filtern